Devyser welcomes Fredrik Alpsten as new CEO starting September 1st. Ulf Klangby, the former CEO and...
Swedish genetic test developer Devyser’s product for hereditary breast and ovarian cancer (HBOC) is...
From June 1st to June 7th 2020 is World Haemochromatosis Week.
Stockholm, 26 may 2020
The 8th of May is World Ovarian Cancer Day. Bringing awareness about this illness is especially...
First and foremost, we are ensuring the well-being of our employees and the continuity of our...
Today is World Cancer Day, as advocated by the Union for International Cancer Control. Their global...
Individual and patient privacy concerns have come back into focus with a recent ruling from a US...
Devyser is excited to announce a new partnership with Biotecnomica in Peru! Our products have now...
Devyser is now searching for 2 new research scientists and a senior scientist to join our research...
Cancer is overtaking heart disease as the leading cause of death, according to a study published...
Devyser is extremely proud to have been recognized as one of Sweden’s best workplaces (Small...
